Contact
Please use this form to send email to PR contact of this press release:
Innovest Global Inc. Signs Letter of Intent to Acquire 20% of StemVax Therapeutics, a Biotechnology & Health Sciences Company
TO:
Please use this form to send email to PR contact of this press release:
Innovest Global Inc. Signs Letter of Intent to Acquire 20% of StemVax Therapeutics, a Biotechnology & Health Sciences Company
TO: